慢性肾脏病(chronic kidney disease,CKD)影响着全球约 10% 的人口,全球疾病负担联盟预计到 2024 年,CKD 将成为影响人类寿命的五大疾病之一。CKD 患者患心血管疾病(cardiovascular disease,CVD)的风险显著增加,包括冠状动脉疾病、心衰、心律失常和心源性猝死。 美国肾脏数据系统(USRDS)2020 年的数据显示,CKD 患者的 CV...
cardiovascular diseasechildrenchronic kidney diseaserenal failurerisk factorsChildren and adolescents with chronic kidney disease (CKD) are at high risk for cardiovascular morbidity and mortality. This review provides a comprehensive overview of the possible risk factors for early atherosclerosis in children ...
1. Matsushita K, Ballew SH, Wang AY, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022 Sep 14.
有效降低CKD患者的心血管疾病风险需要多学科的护理以及进一步的工作,才能解决目前的研究和临床工作之间的鸿沟。 Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.2022-09-14,doi: 10.1038/s41581-022-00616-6. 文章...
Cardiovascular disease is a major complication of chronic kidney disease (CKD), and current data support its link to mineral metabolism disturbances. However, there is an intense debate over whether CKD-mineral and bone disorder therapy could change the cardiovascular burden in CKD. The study by ...
Cardiovascular (CV) disease remains a leading cause of death in CKD patients, who experience a high burden of hypertension, diabetes and CV comorbidity [5]. CV disease burden begins early in CKD, with eGFR <60 mL/min/1.73 m2 and albumin creatinine ratio 30 mg/g being associated with ...
[12]. Liu T, Li R, Wang X, et al. Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: a systemic review and metaanalysis. Med Clin (Barc), 2022, 159(2): 65-72....
The association of chronic kidney disease (CKD) with cardiovascular mortality is well established. According to Mahmut Yilmaz and colleagues, this association may not always be linked to accelerated atherosclerosis.doi:10.1038/nrneph.2010.25Allison
2. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B...
[12] Drechsler C, Krane V, Ritz E, M € arz W, Wanner C. Glycemic control and cardiovascular events in diabetic hemodialysis patients. Circulation 2009;120(24):2421-8. [13] Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar-Zadeh K. Updates on the management of diabetes ...